Vitamin D and atopy and asthma phenotypes in children

Elysia M Hollams1

  • 1Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia. elysiah@ichr.uwa.edu.au

Insights

Low vitamin D levels in children are linked to increased risk of atopy and asthma. Ensuring adequate vitamin D during pregnancy and childhood may help prevent these conditions.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Nutritional Science

Background:

  • Atopy and asthma are significant childhood health concerns.
  • The role of vitamin D in immune system regulation is increasingly recognized.
  • Existing research suggests potential links between vitamin D deficiency and allergic diseases.

Purpose of the Study:

  • To review current research on the association between vitamin D deficiency and childhood atopy and asthma.
  • To explore epidemiological and mechanistic evidence supporting this link.
  • To identify knowledge gaps and future research directions.

Main Methods:

  • Review of recent epidemiological studies correlating vitamin D status with atopy and asthma in children.
  • Analysis of mechanistic studies investigating vitamin D's role in relevant biological processes.
  • Focus on determinants of childhood asthma phenotypes and vitamin D's impact.

Main Results:

  • Vitamin D levels show an inverse association with corticosteroid use, airflow limitation, and exacerbations in asthmatic children.
  • Low vitamin D is linked to atopy and asthma in children and adolescents, particularly in boys.
  • Vitamin D levels at age 6 predicted atopy and asthma outcomes at age 14.
  • Mechanistic studies show vitamin D deficiency in pregnancy leads to reduced lung function in offspring.

Conclusions:

  • Current evidence suggests that maintaining adequate vitamin D levels during pregnancy and childhood may reduce the incidence of atopy and asthma.
  • Further research is needed to determine optimal vitamin D levels, timing, and duration of intervention.
  • Sex and individual variations in vitamin D requirements warrant further investigation.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...